Drug Induced Liver Injury
14
4
4
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
14.3%
2 terminated out of 14 trials
66.7%
-19.8% vs benchmark
7%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Drug-induced Liver Injury: Itching Study
Drug-Induced Liver Injury (DILI) Network Retrospective
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting
Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions
Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi
Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease
Prospective Comparative Validation Study of RUCAM and RECAM
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury
Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury
Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days